We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Test Taken After Miscarriage Can Predict Future Risk of Pregnancy Loss

By LabMedica International staff writers
Posted on 18 May 2023

Approximately 10% of women experience pregnancy loss, a percentage that is higher in regions where pregnancies frequently occur later in a woman's reproductive years. Various factors contribute to pregnancy loss, including hormonal imbalances, endocrine disorders, clotting issues, or lifestyle-related factors. Despite the fact that one in four pregnancies results in a miscarriage, little has been done to investigate the underlying causes, with the primary focus being on the process of uterus evacuation post-miscarriage. Now, a new study has found that a post-miscarriage blood test as early as the fifth week of pregnancy could shed light on the cause and, in some instances, guide preventative treatment strategies. These findings could potentially help prevent 5% of the annual 30 million miscarriages worldwide.

In the study, a team of researchers at Hvidovre Hospital (Hvidovre, Denmark) demonstrated that a blood sample taken from the mother shortly after a miscarriage that occurred as early as the fifth week of pregnancy can identify whether there was a chromosomal abnormality in the fetus. Such tests are typically only administered after a woman has experienced multiple miscarriages and if they occurred past the tenth week of pregnancy.


Image: Early blood test may unravel secrets of pregnancy loss (Photo courtesy of Freepik)
Image: Early blood test may unravel secrets of pregnancy loss (Photo courtesy of Freepik)

This blood test can be immediately dispatched to the hospital laboratory. Here, the fetal DNA is isolated, sequenced, and analyzed for chromosomal abnormalities, which are present in approximately 50 to 60% of miscarriages. This analysis allows doctors to identify the severity of these abnormalities and estimate the risk of future miscarriages. If no abnormalities are detected, doctors can then initiate an in-depth investigation for other causes. If a cause is identified, medical professionals can assess the risks and formulate an appropriate treatment plan.

Related Links:
Hvidovre Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Latest Molecular Diagnostics News

Urine Test to Revolutionize Lyme Disease Testing

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk